Negative reexploration for cardiac postoperative bleeding: Can it be therapeutic?

Annals of Thoracic Surgery

Volumn 65, Issue 4 SUPPL., 1998, Pages 999-1002

  Pelletier, Marc P ^a   Solymoss, Susan ^a   Lee, Andrew ^a   Chiu, Ray C J ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; AMINOCAPROIC ACID; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; FIBRINOLYSIS; HEART SURGERY; HUMAN; MEDIASTINUM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

6-AMINOCAPROIC ACID; AGED; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; ANTITHROMBINS; AORTIC VALVE; BLOOD COAGULATION; CAPILLARIES; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; IRRIGATION; LYSINE; MEDIASTINUM; MICROCIRCULATION; MITRAL VALVE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTOPERATIVE HEMORRHAGE; REOPERATION; SERINE PROTEINASE INHIBITORS;

EID: 0031920277     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4975(98)00078-2     Document Type: Article

References (14)

1. Mehta SM, Pae WE Jr. Complications of cardiac surgery. In: Edmunds LH Jr, ed. Cardiac surgery in the adult, 1 ed. New York: McGraw-Hill, 1997:392-3.
2. Moulton MJ, Creswell LL, Mackey ME, et al. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Card Surg 1996;111:1037-46.
3. Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardio Vasc Anest 1995;9:168-73.
4. Unsworth-White MJ, Herriot A, Valencia O, et al. Resternotomy for bleeding after cardiac operation: a marker for increased morbidity and mortality. Ann Thorac Surg 1995;59:664-7.
5. Collen D, Lijnen HR. Molecular and cellular basis of fibrinolysis. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, eds. Hematology: basic principles and practice. New York: Churchill Livingstone Inc, 1991:1232.
6. Tabuchi N, de Haan J, Boonstra PW, van Oeveren W. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass. J Thorac Card Surg 1993;106:828-33.
7. Rapaport SI. Introduction to hematology, 2 ed. Philadelphia: Lippincott, 1987:464.
8. Vander Salm TJ, Kaur S, Lancy RA, et al. Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. J Thorac Card Surg 1996;112:1098-107.
9. Levy JH, Pifarré R, Schaff HV, et al. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 1995;92:2236-44.
10. Gans H, Krivit W. Problems in hemostasis during open-heart surgery. III: Epsilon amino caproic acid as an inhibitor of plasminogen activator activity. Ann Surg 1962;155:268-76.
11. DelRossi AJ, Cernaianu AC, Botros S, et al. Prophylactic treatment of postperfusion bleeding using EACA. Chest 1989;96:27-30.
12. Arom KV, Emery RW. Decreased postoperative drainage with addition of ∈-aminocaproic acid before cardiopulmonary bypass. Ann Thorac Surg 1994;57:1108-12.
13. Daily PO, Lamphere JA, Dembitsky WP, et al. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting: a randomized, prospective, double-blind study. J Thorac Cardiovasc Surg 1994;108:99-106.
14. Vander Salm TJ, Ansell JE, Okike ON, et al. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study. J Thorac Cardiovasc Surg 1988;95:538-40.